Sign In
Buy HCSG
$20.19
-0.0500 (-0.247%)
At Close: Jun 03, 2026
Merrill Lynch Believes Humana (NYSE: HUM) Won’t Stop Here
09:06am, Thursday, 30'th Apr 2020
In a report released today, Kevin Fischbeck from Merrill Lynch reiterated a Buy rating on Humana (HUM – Research Report),
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by American Investment Services Inc.
08:28am, Thursday, 30'th Apr 2020
American Investment Services Inc. increased its stake in shares of Merck & Co., Inc. (NYSE:MRK) by 6.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Com
Healthcare Services Sees Relative Strength Rating Rise To 73
12:00am, Thursday, 30'th Apr 2020Edited Transcript of HUM earnings conference call or presentation 29-Apr-20 2:00pm GMT
11:34pm, Wednesday, 29'th Apr 2020
Q1 2020 Humana Inc Earnings Call
Wells Fargo Believes Humana (HUM) Won't Stop Here
10:26pm, Wednesday, 29'th Apr 2020
In a report released today, Peter Costa from Wells Fargo maintained a Buy rating on Humana (HUM). The company's shares closed last Wednesday at $377.38,
Wells Fargo Believes Humana (NYSE: HUM) Won’t Stop Here
10:26pm, Wednesday, 29'th Apr 2020
In a report released today, Peter Costa from Wells Fargo maintained a Buy rating on Humana (HUM – Research Report).
Humana's (HUM) Earnings Beat Estimates in Q1, Improve Y/Y
04:45pm, Wednesday, 29'th Apr 2020
Humana's (HUM) first-quarter results reflect better revenues and growth in Medicare Advantage business.
Clark Estates Inc. NY Acquires New Position in Merck & Co., Inc. (NYSE:MRK)
02:53pm, Wednesday, 29'th Apr 2020
Clark Estates Inc. NY acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor
Oppenheimer Believes Humana (HUM) Won't Stop Here
12:16pm, Wednesday, 29'th Apr 2020
In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Humana (HUM), with a price target of $400.00. The company's
Oppenheimer Believes Humana (NYSE: HUM) Won’t Stop Here
12:16pm, Wednesday, 29'th Apr 2020
In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Humana (HUM – Research Report), with
Merck & Company (MRK) Receives a Buy from Barclays
12:15pm, Wednesday, 29'th Apr 2020
Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK) yesterday and set a price target of $90.00. The company's shares closed
Merck & Company (MRK) Receives a Buy from Barclays
12:15pm, Wednesday, 29'th Apr 2020
Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a
Bridgeworth LLC Boosts Stake in Merck & Co., Inc. (NYSE:MRK)
11:02am, Wednesday, 29'th Apr 2020
Bridgeworth LLC increased its position in Merck & Co., Inc. (NYSE:MRK) by 5.3% during the first quarter, Holdings Channel.com reports. The institutional investor owned 2,689 shares of the company’s
Blue Fin Capital Inc. Has $2.22 Million Stake in Merck & Co., Inc. (NYSE:MRK)
11:02am, Wednesday, 29'th Apr 2020
Blue Fin Capital Inc. decreased its stake in Merck & Co., Inc. (NYSE:MRK) by 1.0% in the 1st quarter, Holdings Channel.com reports. The fund owned 28,843 shares of the company’s stock after selling
Merck & Company (MRK) Gets a Buy Rating from Leerink Partners
10:58am, Wednesday, 29'th Apr 2020
In a report released today, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK), with a price target of $95.00. The
